POCARED Diagnostics Ltd is an Israeli-based in-vitro diagnostic and pre-analytical technology manufacturer with offices in the US. POCARED’s™ SP is a general purpose pre-analytical platform which concentrates samples.
POCARED announces a breakthrough in pre-analytical technologies and systems with its novel Gram stain methodology. POCARED introduces the first system that can perform both direct, automated Gram staining and sample concentration. The performance will be presented at the ASM 2015 General Meeting, May 30 to June 2 in New Orleans, LA
“The versatility of POCARED’s SP demonstrates how POCARED is revolutionizing laboratory practice. Our SP platform now offers an automated Gram stain in addition to sample concentration, purification and homogenization with second-to-none performance. POCARED’s SP is a general-use platform that has applications in many of the newer laboratory technologies” says Jonathan Gurfinkel, President and CEO of the company.
Addressing a market of annual 35 million tests in the US alone and more than double of that number worldwide, POCARED continues to develop solutions for high volume test types. POCARED’s SP will be exhibited in booth number 211 at the meeting. POCARED will demonstrate the platform that provides both gram stain and second to-none cell recovery, viability, and robust fractionation capabilities.
About the company
POCARED Diagnostics Ltd is an in-vitro diagnostic and pre-analytics company utilizing cutting edge technologies to deliver next generation platforms. POCARED’s CULTURE-FREE Microbiology® technology is revolutionizing infectious disease diagnosis and practice with real-time automated results. POCARED’s P- 1000™ platform is fully automated, reagent- free, real time and easy to operate. It provides multi-source detection, quantification and species identification for bacteria and yeast in a few minutes directly from sample. This saves several critical days in reporting compared to current practices. POCARED’s SP is the next generation general-use pre-analytical platform which uses rapid filtration-based concentration. This technology introduces second-to-none organism recovery, viability and robust fractionation capabilities.
For more information please email [email protected]